These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 9557230)
1. Resistance to erythromycin and clindamycin in cutaneous propionibacteria is associated with mutations in 23S rRNA. Ross JI; Eady EA; Cove JH; Ratyal AH; Cunliffe WJ Dermatology; 1998; 196(1):69-70. PubMed ID: 9557230 [No Abstract] [Full Text] [Related]
2. Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA. Ross JI; Eady EA; Cove JH; Jones CE; Ratyal AH; Miller YW; Vyakrnam S; Cunliffe WJ Antimicrob Agents Chemother; 1997 May; 41(5):1162-5. PubMed ID: 9145890 [TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne. Schafer F; Fich F; Lam M; Gárate C; Wozniak A; Garcia P Int J Dermatol; 2013 Apr; 52(4):418-25. PubMed ID: 23432195 [TBL] [Abstract][Full Text] [Related]
4. MLST typing of antimicrobial-resistant Propionibacterium acnes isolates from patients with moderate to severe acne vulgaris. Giannopoulos L; Papaparaskevas J; Refene E; Daikos G; Stavrianeas N; Tsakris A Anaerobe; 2015 Feb; 31():50-4. PubMed ID: 25451716 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris. Ishida N; Nakaminami H; Noguchi N; Kurokawa I; Nishijima S; Sasatsu M Microbiol Immunol; 2008 Dec; 52(12):621-4. PubMed ID: 19120976 [TBL] [Abstract][Full Text] [Related]
6. Resistance of propionibacteria to antibiotics used in the treatment of acne. Brown JM; Poston SM J Med Microbiol; 1983 Aug; 16(3):271-80. PubMed ID: 6224016 [TBL] [Abstract][Full Text] [Related]
7. A novel 23S rRNA mutation in Propionibacterium acnes confers resistance to 14-membered macrolides. Nakase K; Nakaminami H; Takenaka Y; Hayashi N; Kawashima M; Noguchi N J Glob Antimicrob Resist; 2016 Sep; 6():160-161. PubMed ID: 27530860 [No Abstract] [Full Text] [Related]
8. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia. Ross JI; Snelling AM; Eady EA; Cove JH; Cunliffe WJ; Leyden JJ; Collignon P; Dréno B; Reynaud A; Fluhr J; Oshima S Br J Dermatol; 2001 Feb; 144(2):339-46. PubMed ID: 11251569 [TBL] [Abstract][Full Text] [Related]
9. Laboratory induction and clinical occurrence of combined clindamycin and erythromycin resistance in Corynebacterium acnes. Crawford WW; Crawford IP; Stoughton RB; Cornell RC J Invest Dermatol; 1979 Apr; 72(4):187-90. PubMed ID: 429800 [TBL] [Abstract][Full Text] [Related]
11. In vivo antibacterial effects of tretinoin-clindamycin and clindamycin alone on Propionibacterium acnes with varying clindamycin minimum inhibitory. Leyden JJ J Drugs Dermatol; 2012 Dec; 11(12):1434-8. PubMed ID: 23377513 [TBL] [Abstract][Full Text] [Related]
12. Functional interactions within 23S rRNA involving the peptidyltransferase center. Douthwaite S J Bacteriol; 1992 Feb; 174(4):1333-8. PubMed ID: 1531223 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains. Gloor M; Wasik B; Becker A; Höffler U Dermatology; 2002; 205(3):260-4. PubMed ID: 12399674 [TBL] [Abstract][Full Text] [Related]
14. Activity of the novel macrolide BAL19403 against ribosomes from erythromycin-resistant Propionibacterium acnes. Dreier J; Amantea E; Kellenberger L; Page MG Antimicrob Agents Chemother; 2007 Dec; 51(12):4361-5. PubMed ID: 17923495 [TBL] [Abstract][Full Text] [Related]
15. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Eady EA; Cove JH; Holland KT; Cunliffe WJ Br J Dermatol; 1989 Jul; 121(1):51-7. PubMed ID: 2527056 [TBL] [Abstract][Full Text] [Related]
16. [In vitro sensitivity of Corynebacterium acnes (Propionibacterium acnes) to meclocycline, clindamycin, erythromycin and neomycin]. Lucca L; Vittadini G G Ital Chemioter; 1979; 26(1-2):203-6. PubMed ID: 554810 [No Abstract] [Full Text] [Related]
17. Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin. Pereyre S; Renaudin H; Charron A; Bébéar C; Bébéar CM J Antimicrob Chemother; 2006 Apr; 57(4):753-6. PubMed ID: 16464889 [TBL] [Abstract][Full Text] [Related]
18. In vitro activity of kaempferol isolated from the Impatiens balsamina alone and in combination with erythromycin or clindamycin against Propionibacterium acnes. Lim YH; Kim IH; Seo JJ J Microbiol; 2007 Oct; 45(5):473-7. PubMed ID: 17978809 [TBL] [Abstract][Full Text] [Related]
19. Identification of A2059G 23S rRNA and G439A rplC gene mutations in Streptococcus criceti strain OMZ 61, a strain resistant to azithromycin, josamycin and clindamycin. Tamura H; Yamada A; Kato H Genes Genet Syst; 2015; 90(5):259-67. PubMed ID: 26725523 [TBL] [Abstract][Full Text] [Related]
20. A point mutation associated with bacterial macrolide resistance is present in both 23S rRNA genes of an erythromycin-resistant Treponema pallidum clinical isolate. Stamm LV; Bergen HL Antimicrob Agents Chemother; 2000 Mar; 44(3):806-7. PubMed ID: 10755994 [No Abstract] [Full Text] [Related] [Next] [New Search]